SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,178.06 |
| Enterprise Value ($M) | 3,219.60 |
| Book Value ($M) | 228.54 |
| Book Value / Share | 1.82 |
| Price / Book | 13.91 |
| NCAV ($M) | 132.44 |
| NCAV / Share | 1.06 |
| Price / NCAV | 24.00 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.28 |
| Return on Assets (ROA) | -0.25 |
| Return on Equity (ROE) | -1.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.81 |
| Current Ratio | 4.25 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 788.95 |
| Assets | 885.05 |
| Liabilities | 656.51 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 781.37 |
| Operating Income | -164.98 |
| Net Income | -197.88 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -87.87 |
| Cash from Investing | -0.40 |
| Cash from Financing | 149.24 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Wellington Management Group Llp | 9.50 | -24.14 | |
| 13G | Morgan Stanley | 7.70 | ||
| 13G/A | Deep Track Capital, LP | 4.82 | ||
| 13G/A | T. Rowe Price Investment Management, Inc. | 2.50 | -52.64 | |
| 13G | BlackRock, Inc. | 5.10 | 0.00 | |
| 13G/A | EcoR1 Capital, LLC | 9.40 | 77.14 | |
| 13G/A | Avoro Capital Advisors LLC | 9.90 | 26.22 | |
| 13G/A | Vanguard Group Inc | 8.06 | 3.73 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 95,606 | 840,152 | 11.38 | |
| 97,435 | 612,577 | 15.91 | |
| 115,556 | 769,115 | 15.02 | |
| 223,086 | 1,219,475 | 18.29 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AMRX – Amneal Pharmaceuticals, Inc. | ANAB – AnaptysBio, Inc. |
| ANNX – Annexon, Inc. | ARQT – Arcutis Biotherapeutics, Inc. |
| ARVN – Arvinas, Inc. |
Financial data and stock pages provided by
Fintel.io